Wed / Apr 24th
by
California lawmakers in the Senate Public Safety Committee voted to advance a proposal that would establish treatment centers where adults aged 21+ could access psilocybin, MDMA, DMT, and other psychedelics.
Full story after the jump.
a word from our sponsors:
become a sponsor
advertisement
advertise here
California senators voted on Tuesday to advance a bill that would establish treatment centers in the state where adults aged 21 or older could access psychedelics including psilocybin, psilocyn, DMT, MDMA, and mescaline while under supervision, Marijuana Moment reports.
The “Regulated Therapeutic Access to Psychedelics Act” passed the Senate Business, Professions and Economic Development Committee earlier this month, and the Public Safety Committee voted 3-2 this week to advance the proposal to the Appropriations Committee for consideration.
Sponsored by Sen. Scott Wiener (D), the proposal creates regulated access points for psychedelic substances but would not remove criminal penalties outside of that environment. Additionally, participants in the program would need to submit to a health and safety screening. Other provisions of the bill include training and licensing requirements for those who would facilitate psychedelics, the creation of a “Division of Regulated Psychedelic-Assisted Therapy” that would regulate the program, and new licensing procedures for the program’s producers and testing labs. The bill would also fund public education initiatives covering the safe use of psychedelics and their potential risks and benefits.
“People are using psychedelics today. There is incredible potential in terms of treating mental health and substance use disorders. And we should bring it into the sunlight so people can use safely in a supervised, structured setting.” — Wiener, via Marijuana Moment
The bill was crafted to appease requests by Gov. Gavin Newsom (D), who last year vetoed a proposal that sought to decriminalize certain natural psychedelics. At the time, the governor urged lawmakers to send him a different proposal “that includes therapeutic guidelines.”
Get daily cannabis business news updates. Subscribe
Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.
Note: our editors approve comments that provide new and succinct insight to our audience. If your comment is chosen for publishing, it will appear at the end of the article along with your name, job title, and organization. If you have a profile in the Ganjapreneur Business Index, your comment will also include a backlink for reference. If you are suggesting a correction, we will look into the issue further.
End
Authored By:
Based in Portland, Oregon, Graham is Ganjapreneur’s Chief Editor. He has been writing about the legalization landscape since 2012 and has been contributing to Ganjapreneur since our official launch in 2014.
a word from our sponsors:
become a sponsor
a word from our sponsors:
become a sponsor
advertisement
advertise here
Wed / Apr 24th
Mon / Apr 22nd
Mon / Apr 22nd
Mon / Apr 22nd
Mon / Apr 22nd
Mon / Apr 22nd
View all news Get email updates
Create a profile View all categories
Angela Schweers
Kyle Loucks
AROYA
a word from our sponsors:
become a sponsor
advertisement
advertise here
Esssential cannabis industry news & insights, delivered daily.
Trusted cannabis business intelligence.
Copyright 2024 © Ganjapreneur.com // All rights reserved. // Terms of Use // Advertising Policy // Privacy Policy
DISCLAIMER: Ganjapreneur.com is intended as an educational resource for law-abiding professionals and those who are curious about entrepreneurial and/or investment opportunities in emerging markets. We do not offer investment advice, and we encourage all visitors and readers to do their own due dilligence before investing in any of the companies or markets that we write about. Be advised that possessing, using, distributing and selling cannabis are all federal crimes in the United States of America and the articles, pages, links, and other types of information on this site are not intended to assist you in violating federal law. Ganjapreneur.com and all associated entities and individuals are not responsible for third party content and/or links published on this website.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.